FDA Grant: Developing an Evidence-Based Clinical Practice Guideline for Safe Acute Low Back Pain Management

• Public/State Controlled Institutions of Higher Education

• Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education:

o Hispanic-serving Institutions

o Historically Black Colleges and Universities (HBCUs)

o Tribally Controlled Colleges and Universities (TCCUs)

o Alaska Native and Native Hawaiian Serving Institutions

o Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

· Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)

· Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations

· Small Businesses

· For-Profit Organizations (Other than Small Businesses)

Local Governments

· State Governments

· County Governments

· City or Township Governments

· Special District Governments

· Indian/Native American Tribal Governments (Federally Recognized)

· Indian/Native American Tribal Governments (Other than Federally Recognized)

Other

· Independent School Districts

· Public Housing Authorities/Indian Housing Authorities

· Native American Tribal Organizations (other than Federally recognized tribal governments)

· Faith-based or Community-based Organizations

· Regional Organizations

Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.

The U.S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the management of acute low back pain. Applicants must propose a comprehensive evidence-based plan that advances safe prescribing of opioid analgesics for patients who have acute low back pain.